294 related articles for article (PubMed ID: 8767335)
1. [Results of elective lymph node excision in melanoma of the trunk].
Zimmermann T; Buhr J; Kelm C; Padberg W
Zentralbl Chir; 1996; 121(6):478-82. PubMed ID: 8767335
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of elective lymph node dissection in malignant melanoma of the extremities and trunk. An analysis in view of the sentinel lymph node biopsy].
Zimmermann T; Andresen S; Schmitt H; Padberg W
Zentralbl Chir; 2001 Apr; 126(4):279-82. PubMed ID: 11370389
[TBL] [Abstract][Full Text] [Related]
3. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
Cole DJ; Baron PL
Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
6. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991.
Coates AS; Ingvar CI; Petersen-Schaefer K; Shaw HM; Milton GW; O'Brien CJ; Thompson JF; McCarthy WH
J Am Coll Surg; 1995 Apr; 180(4):402-9. PubMed ID: 7719543
[TBL] [Abstract][Full Text] [Related]
7. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
[TBL] [Abstract][Full Text] [Related]
8. Regional lymph node dissections in malignant melanoma.
Lawton GP; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
Queirolo P; Taveggia P; Gipponi M; Sertoli MR
J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
[TBL] [Abstract][Full Text] [Related]
10. [Value of lymphatic outflow directed continuity dissection in melanoma surgery].
Winter H; Aurisch R; Küchler I
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():115-7. PubMed ID: 9101803
[TBL] [Abstract][Full Text] [Related]
11. The case for minimal margins and delayed regional node dissection for high-risk cutaneous melanoma.
Cascinelli N; Belli F
Curr Opin Gen Surg; 1993; ():310-5. PubMed ID: 7584000
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma.
McCarthy WH; Shaw HM; Milton GW
Surg Gynecol Obstet; 1985 Dec; 161(6):575-80. PubMed ID: 4071371
[TBL] [Abstract][Full Text] [Related]
13. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
[TBL] [Abstract][Full Text] [Related]
15. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
16. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
18. Elective and therapeutic regional lymph node dissection for cutaneous malignant melanoma: experience of the British Columbia Cancer Agency, 1972 to 1981.
Carmichael VE; Robins RE; Wilson KS
Can J Surg; 1992 Dec; 35(6):600-4. PubMed ID: 1458385
[TBL] [Abstract][Full Text] [Related]
19. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
